Food and Insulin Effect on QT/QTC Interval of ECG

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Effects of Different Meals on the QT/QTc IntervalInsulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic UseC-Peptide Effects on the QT/QTc IntervalMoxifloxacin ECG Profile in Fed and Fasted StateJapanese vs. Caucasian TQT Comparison
Interventions
DRUG

Moxifloxacin 400 mg fasted

"Subjects receiving drug (400 mg moxifloxacin),having fasted overnight for 10 hours.~This is the standard probe for the assessment of assay sensitivity in Thorough QT (TQT) studies."

OTHER

FDA breakfast

Calorie reduced FDA standard breakfast (58% fat, low carbohydrates)- On the assumption that increases in C-peptide levels are responsible for the QTc shortening observed after a meal, a lesser effect on QTc compared to a carbohydrate rich breakfast should be observed.

OTHER

Continental breakfast

High carbohydrate breakfast (\>70% carbohydrates)- On the assumption that increases in C-peptide levels are responsible for the QTc shortening observed after a meal, a greater effect on QTc compared to a low carbohydrate breakfast (FDA standard breakfast) should be observed.

DRUG

Moxifloxacin 400 mg fed

Currently, there is no published data showing the effects of a single 400 mg oral dose of moxifloxacin on the ECG/QT/QTc after food.

PROCEDURE

Insulin Clamp

A euglycaemic/hyperinsulinaemic clamp, (DeFronzo, 1979) involves acutely raising the plasma insulin levels to a steady state and maintaining a state of euglycaemia with a glucose infusion, thereby effectively stopping endogenous insulin and C-peptide release. This technique will confirm whether hyperinsulinaemia has any effect on the QT/QTc interval.

DRUG

Placebo

Comparison of different meals effect on Moxifloxacin PK profile

Trial Locations (1)

SW17 0RE

Richmond Pharmacology Ltd, London

All Listed Sponsors
lead

Richmond Pharmacology Limited

INDUSTRY

NCT01642485 - Food and Insulin Effect on QT/QTC Interval of ECG | Biotech Hunter | Biotech Hunter